CS logo
small CS logo
Cancer Care Associates - Mercy Campus

Oklahoma City, Oklahoma, United States

About Cancer Care Associates - Mercy Campus


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Cancer Care Associates - Mercy Campus


During the past decade, Cancer Care Associates - Mercy Campus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 12 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men
2004-04-01
2007-08-01
Completed
288
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
2007-05-15
2018-05-14
Terminated
836
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
2007-10-31
2011-01-31
Completed
132
Methotrexate-Inadequate Response Study
2008-01-01
2014-09-01
Completed
2,492
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
2009-09-01
2012-12-01
Completed
201
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
2009-09-01
2010-09-01
Completed
99
A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections
2009-11-17
2011-03-01
Terminated
679

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Cancer Care Associates - Mercy Campus" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 12 trials, followed by "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Eisai Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Associates - Mercy Campus" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Aptuit" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Cancer Care Associates - Mercy Campus


According to Clinical.Site data, the most researched conditions in "Cancer Care Associates - Mercy Campus" are "Breast Cancer" (9 trials), "Lung Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Melanoma (Skin)" (2 trials) and "Acute Leukemia" (1 trials). Many other conditions were trialed in "Cancer Care Associates - Mercy Campus" in a lesser frequency.

Clinical Trials Intervention Types at Cancer Care Associates - Mercy Campus


Most popular intervention types in "Cancer Care Associates - Mercy Campus" are "Drug" (18 trials), "Biological" (8 trials), "Other" (7 trials), "Radiation" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (5 trials), "bevacizumab" (3 trials), "cyclophosphamide" (3 trials), "paclitaxel" (3 trials) and "AC regimen" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Cancer Care Associates - Mercy Campus


The vast majority of trials in "Cancer Care Associates - Mercy Campus" are 16 trials for "All" genders and 6 trials for "Female" genders.

Clinical Trials Status at Cancer Care Associates - Mercy Campus


Currently, there are NaN active trials in "Cancer Care Associates - Mercy Campus". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Cancer Care Associates - Mercy Campus, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Care Associates - Mercy Campus, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status